Storia della carriera di Kamalam Unninayar
Precedenti posizioni note di Kamalam Unninayar
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HARVARD BIOSCIENCE, INC. | Direttore Finanziario/CFO | 26/11/2018 | 31/05/2019 |
| TETRAPHASE PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 16/10/2017 | 16/03/2018 |
Formazione di Kamalam Unninayar
| Wichita State University | Graduate Degree |
| University of Delhi | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| India | 2 |
Posizioni
| Director of Finance/CFO | 2 |
| Graduate Degree | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HARVARD BIOSCIENCE, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Kamalam Unninayar
- Esperienza
